TWO · Healthcare

HeXun Biosciences Co., Ltd. (6986)

Biotechnology

HeXun Biosciences Co., Ltd. (6986) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6986

P/E ratio

25.00

HeXun Biosciences Co., Ltd. (6986) — FAQ

What is 6986's P/E ratio?

The price-to-earnings (P/E) ratio for HeXun Biosciences Co., Ltd. (6986) is 25.00 (data as of 2026-05-23).

Does HeXun Biosciences Co., Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for HeXun Biosciences Co., Ltd. (6986). Check the MyAverix Finance app for the latest dividend data.

What sector is HeXun Biosciences Co., Ltd. in?

HeXun Biosciences Co., Ltd. (6986) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6986 listed on?

6986 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)